寄生虫・菌類迅速検査およびPOC:医療機器パイプライン分析2017

【英語タイトル】Parasitology & Mycology Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2017

GlobalDataが出版した調査資料(GDME0431EPD)・商品コード:GDME0431EPD
・発行会社(調査会社):GlobalData
・発行日:2017年9月1日
・ページ数:90
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥856,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,284,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Parasitology & Mycology Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Parasitology & Mycology Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2017″ provides an overview of Parasitology & Mycology Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Parasitology & Mycology Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Parasitology & Mycology Rapid Tests & Point of Care (POC) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Parasitology & Mycology Rapid Tests & Point of Care (POC) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Parasitology & Mycology Rapid Tests & Point of Care (POC) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Parasitology & Mycology Rapid Tests & Point of Care (POC) Overview 9
3 Products under Development 10
3.1 Parasitology & Mycology Rapid Tests & Point of Care (POC) – Pipeline Products by Stage of Development 10
3.2 Parasitology & Mycology Rapid Tests & Point of Care (POC) – Pipeline Products by Territory 11
3.3 Parasitology & Mycology Rapid Tests & Point of Care (POC) – Pipeline Products by Regulatory Path 12
3.4 Parasitology & Mycology Rapid Tests & Point of Care (POC) – Pipeline Products by Estimated Approval Date 13
4 Parasitology & Mycology Rapid Tests & Point of Care (POC) – Pipeline Products under Development by Companies 14
4.1 Parasitology & Mycology Rapid Tests & Point of Care (POC) Companies – Pipeline Products by Stage of Development 14
4.2 Parasitology & Mycology Rapid Tests & Point of Care (POC) – Pipeline Products by Stage of Development 16
5 Parasitology & Mycology Rapid Tests & Point of Care (POC) Companies and Product Overview 18
5.1 Abingdon Health Ltd Company Overview 18
5.1.1 Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Access Bio Inc Company Overview 19
5.2.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 AdvanDx Inc Company Overview 21
5.3.1 AdvanDx Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Akers Biosciences Inc Company Overview 22
5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Ampath Trust Company Overview 23
5.5.1 Ampath Trust Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Amplino B.V. Company Overview 24
5.6.1 Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 Antigen Discovery Inc Company Overview 25
5.7.1 Antigen Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 Atlas Genetics Ltd Company Overview 26
5.8.1 Atlas Genetics Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Atomo Diagnostics Pty Limited Company Overview 27
5.9.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 BBB Technologies Inc Company Overview 28
5.10.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.11 Bruker Daltonik GmbH Company Overview 29
5.11.1 Bruker Daltonik GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
5.12 Ceres Nanosciences Inc Company Overview 30
5.12.1 Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.13 Chembio Diagnostic Systems Inc Company Overview 31
5.13.1 Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.14 CrossLife Technologies Inc Company Overview 32
5.14.1 CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.15 DetectoGen Inc Company Overview 33
5.15.1 DetectoGen Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.16 DxDiscovery, Inc. Company Overview 34
5.16.1 DxDiscovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.17 DxNA LLC Company Overview 36
5.17.1 DxNA LLC Pipeline Products & Ongoing Clinical Trials Overview 36
5.18 Eiken Chemical Co Ltd Company Overview 37
5.18.1 Eiken Chemical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
5.19 Fast-track diagnostics S.a.r.l. Company Overview 38
5.19.1 Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 38
5.20 Foundation for Innovative New Diagnostics Company Overview 40
5.20.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 40
5.21 genedrive plc Company Overview 42
5.21.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 42
5.22 GenePOC Inc Company Overview 43
5.22.1 GenePOC Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.23 GlucoSentient Inc Company Overview 44
5.23.1 GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.24 Group K Diagnostics Company Overview 45
5.24.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 45
5.25 Innova Biotechnology Co Ltd Company Overview 46
5.25.1 Innova Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
5.26 Institute for Development Research Company Overview 47
5.26.1 Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview 47
5.27 Institute of Molecular Biology of Parana Company Overview 49
5.27.1 Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 49
5.28 Labsystems Diagnostics Oy Company Overview 50
5.28.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 50
5.29 Makerere University Company Overview 51
5.29.1 Makerere University Pipeline Products & Ongoing Clinical Trials Overview 51
5.30 mBio Diagnostics Inc Company Overview 52
5.30.1 mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.31 Meridian Bioscience Inc Company Overview 53
5.31.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.32 Meru University of Science & Technology Company Overview 54
5.32.1 Meru University of Science & Technology Pipeline Products & Ongoing Clinical Trials Overview 54
5.33 Micronics Inc Company Overview 55
5.33.1 Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview 55
5.34 Molbio Diagnostics Pvt. Ltd. Company Overview 57
5.34.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57
5.35 MycoMed Technologies, LLC Company Overview 58
5.35.1 MycoMed Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.36 NG Biotech Company Overview 59
5.36.1 NG Biotech Pipeline Products & Ongoing Clinical Trials Overview 59
5.37 NOWDiagnostics Company Overview 61
5.37.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 61
5.38 PATH medical GmbH Company Overview 63
5.38.1 PATH medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 63
5.39 Protein Advances Inc Company Overview 64
5.39.1 Protein Advances Inc Pipeline Products & Ongoing Clinical Trials Overview 64
5.40 Singapore Immunology Network Company Overview 65
5.40.1 Singapore Immunology Network Pipeline Products & Ongoing Clinical Trials Overview 65
5.41 Stanford University Company Overview 66
5.41.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 66
5.42 Technical University of Munich Company Overview 67
5.42.1 Technical University of Munich Pipeline Products & Ongoing Clinical Trials Overview 67
5.43 University of Delhi Company Overview 68
5.43.1 University of Delhi Pipeline Products & Ongoing Clinical Trials Overview 68
5.44 University of Nevada Reno Company Overview 69
5.44.1 University of Nevada Reno Pipeline Products & Ongoing Clinical Trials Overview 69
5.45 Vanderbilt University Company Overview 72
5.45.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 72
5.46 Whidiag SAS Company Overview 73
5.46.1 Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview 73
6 Parasitology & Mycology Rapid Tests & Point of Care (POC)- Recent Developments 74
6.1 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 74
6.2 Jul 10, 2017: DxNA LLC Announces 510(K) Submission of the GeneSTAT Analyzer and GeneSTAT Coccidioides Assay 75
6.3 Jun 13, 2017: TECHLAB Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite 76
6.4 May 16, 2017: NOWDiagnostics CEO Kevin Clark to Address Technology Conference 77
6.5 Apr 27, 2017: Trinity Biotech Announces Results for Q1, 2017 77
6.6 Apr 25, 2017: Alere Launches the Alere Malaria Ag P.f, the First-Ever Rapid Test to Screen Malaria Infection in Asymptomatic Individuals 78
6.7 Mar 29, 2017: Omega Diagnostics Announces VISITECT Malaria CE-Mark and successful Indian FDA inspection 80
6.8 Mar 29, 2017: Omega Diagnostics Group: VISITECT Malaria Pf/PAN CE-Mark and successful Indian FDA inspection 80
6.9 Mar 29, 2017: Omega Diagnostics Group Announces CE-Mark Approval for VISITECT Malaria Pf/Pv and successful Indian FDA inspection 80
6.10 Mar 14, 2017: Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results 81
6.11 Nov 03, 2016: GenePOC Announces Setup of an Extensive Network of Commercial Partners Across Europe for Distribution 83
6.12 Oct 25, 2016: Trinity Biotech announces Quarter 3 Financial Results 84
6.13 Sep 06, 2016: Cepheid’s Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men 86
7 Appendix 87
7.1 Methodology 87
7.2 About GlobalData 90
7.3 Contact Us 90
7.4 Disclaimer 90

1.1 List of Tables
Table 1: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 10
Table 2: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 11
Table 3: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 12
Table 4: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 13
Table 5: Parasitology & Mycology Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 14
Table 6: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 16
Table 7: Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
Table 8: Rapid Molecular Diagnostic Test - Malaria - Product Status 18
Table 9: Rapid Molecular Diagnostic Test - Malaria - Product Description 18
Table 10: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 11: ICT - Malaria RDT - Product Status 19
Table 12: ICT - Malaria RDT - Product Description 19
Table 13: Malaria Serology Test - Product Status 20
Table 14: Malaria Serology Test - Product Description 20
Table 15: AdvanDx Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 16: Candida QuickFISH - Product Status 21
Table 17: Candida QuickFISH - Product Description 21
Table 18: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 19: PIFA PLUSS Malaria Rapid Assay - Product Status 22
Table 20: PIFA PLUSS Malaria Rapid Assay - Product Description 22
Table 21: Ampath Trust Pipeline Products & Ongoing Clinical Trials Overview 23
Table 22: CAA UCP - LF Test Strip - Product Status 23
Table 23: CAA UCP - LF Test Strip - Product Description 23
Table 24: Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 25: Scout POC Assay - Product Status 24
Table 26: Scout POC Assay - Product Description 24
Table 27: Antigen Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 28: Microfluidic Point of Care Device - Product Status 25
Table 29: Microfluidic Point of Care Device - Product Description 25
Table 30: Atlas Genetics Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: Atlas io System - Trichomonas Vaginalis - Product Status 26
Table 32: Atlas io System - Trichomonas Vaginalis - Product Description 26
Table 33: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 27
Table 34: AtomoRapid - Malaria - Product Status 27
Table 35: AtomoRapid - Malaria - Product Description 27
Table 36: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 37: Mobile RDT Reader - Malaria Test - Product Status 28
Table 38: Mobile RDT Reader - Malaria Test - Product Description 28
Table 39: Bruker Daltonik GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
Table 40: MALDI Biotyper - Fungal Infection - Product Status 29
Table 41: MALDI Biotyper - Fungal Infection - Product Description 29
Table 42: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 43: Nanotrap Malaria Test - Product Status 30
Table 44: Nanotrap Malaria Test - Product Description 30
Table 45: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 46: DPP Malaria - Product Status 31
Table 47: DPP Malaria - Product Description 31
Table 48: CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 49: Point-Of-Care Diagnostic Assay - Dengue - Product Status 32
Table 50: Point-Of-Care Diagnostic Assay - Dengue - Product Description 32
Table 51: DetectoGen Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 52: Antigen Detection Test - Kala Azar - Product Status 33
Table 53: Antigen Detection Test - Kala Azar - Product Description 33
Table 54: DxDiscovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 55: Diagnostic Assay - Candidiasis - Product Status 34
Table 56: Diagnostic Assay - Candidiasis - Product Description 34
Table 57: Diagnostic Assay - Crytococcosis - Product Status 35
Table 58: Diagnostic Assay - Crytococcosis - Product Description 35
Table 59: DxNA LLC Pipeline Products & Ongoing Clinical Trials Overview 36
Table 60: Valley Fever Test - Product Status 36
Table 61: Valley Fever Test - Product Description 36
Table 62: Eiken Chemical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
Table 63: LAMP Test - Chagas Disease - Product Status 37
Table 64: LAMP Test - Chagas Disease - Product Description 37
Table 65: Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 66: FTD Dermatophytes Assay - Product Status 38
Table 67: FTD Dermatophytes Assay - Product Description 38
Table 68: FTD Stool Parasites Assay - Product Status 39
Table 69: FTD Stool Parasites Assay - Product Description 39
Table 70: Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 40
Table 71: Infection Detection Test - P. falciparum - Product Status 40
Table 72: Infection Detection Test - P. falciparum - Product Description 40
Table 73: P. vivax Serology Test - Product Status 41
Table 74: P. vivax Serology Test - Product Description 41
Table 75: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 76: Genedrive - Malaria Assay - Product Status 42
Table 77: Genedrive - Malaria Assay - Product Description 42
Table 78: GenePOC Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 79: revogene - Candida albicans Assay - Product Status 43
Table 80: revogene - Candida albicans Assay - Product Description 43
Table 81: GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 82: Point-Of-Care Screening Assay - Fungal Infections - Product Status 44
Table 83: Point-Of-Care Screening Assay - Fungal Infections - Product Description 44
Table 84: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 45
Table 85: Multidiagnostic - Malaria Test - Product Status 45
Table 86: Multidiagnostic - Malaria Test - Product Description 45
Table 87: Innova Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Table 88: Rapid Test - Malaria - Product Status 46
Table 89: Rapid Test - Malaria - Product Description 46
Table 90: Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview 47
Table 91: Diagnostic Test - Amebiasis - Product Status 47
Table 92: Diagnostic Test - Amebiasis - Product Description 47
Table 93: Rapid Diagnostic Test - American Tegumentary Leishmaniasis - Product Status 48
Table 94: Rapid Diagnostic Test - American Tegumentary Leishmaniasis - Product Description 48
Table 95: Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 49
Table 96: Point-of-Care Diagnostic Test - Chagas Disease - Product Status 49
Table 97: Point-of-Care Diagnostic Test - Chagas Disease - Product Description 49
Table 98: Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 50
Table 99: Biocard Malaria Test - Product Status 50
Table 100: Biocard Malaria Test - Product Description 50
Table 101: Makerere University Pipeline Products & Ongoing Clinical Trials Overview 51
Table 102: Diagnostic Test - African Trypanosomiasis - Product Status 51
Table 103: Diagnostic Test - African Trypanosomiasis - Product Description 51
Table 104: mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 105: POC Diagnostic Device - Malaria - Product Status 52
Table 106: POC Diagnostic Device - Malaria - Product Description 52
Table 107: Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 108: Illumigene Babesia Assay - Product Status 53
Table 109: Illumigene Babesia Assay - Product Description 53
Table 110: Meru University of Science & Technology Pipeline Products & Ongoing Clinical Trials Overview 54
Table 111: Rapid Diagnostic Test - African Trypanosomiasis - Product Status 54
Table 112: Rapid Diagnostic Test - African Trypanosomiasis - Product Description 54
Table 113: Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 114: PanNAT - Malaria Assay - Product Status 55
Table 115: PanNAT - Malaria Assay - Product Description 55
Table 116: PanNAT - TV Assay - Product Status 56
Table 117: PanNAT - TV Assay - Product Description 56
Table 118: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57
Table 119: Truenat Trichomonas Assay - Product Status 57
Table 120: Truenat Trichomonas Assay - Product Description 57
Table 121: MycoMed Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
Table 122: AspUTest - Product Status 58
Table 123: AspUTest - Product Description 58
Table 124: NG Biotech Pipeline Products & Ongoing Clinical Trials Overview 59
Table 125: NG-Quant Pf/Malaria Test - Product Status 59
Table 126: NG-Quant Pf/Malaria Test - Product Description 59
Table 127: NG-Telediag pf/Pan Test - Product Status 60
Table 128: NG-Telediag pf/Pan Test - Product Description 60
Table 129: NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 61
Table 130: ADEXUSDx Test - Malaria - Product Status 61
Table 131: ADEXUSDx Test - Malaria - Product Description 61
Table 132: ADEXUSDx Trichomoniasis Test - Product Status 62
Table 133: ADEXUSDx Trichomoniasis Test - Product Description 62
Table 134: PATH medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 63
Table 135: PATH Chagas Immunochromatographic Strip Test - Product Status 63
Table 136: PATH Chagas Immunochromatographic Strip Test - Product Description 63
Table 137: Protein Advances Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 138: Diagnostic Test - Human African Trypanosomiasis - Product Status 64
Table 139: Diagnostic Test - Human African Trypanosomiasis - Product Description 64
Table 140: Singapore Immunology Network Pipeline Products & Ongoing Clinical Trials Overview 65
Table 141: Rapid Diagnostic Assay - Malaria - Product Status 65
Table 142: Rapid Diagnostic Assay - Malaria - Product Description 65
Table 143: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 66
Table 144: Rapid Antibody Test - Soil-Transmitted Helminths - Product Status 66
Table 145: Rapid Antibody Test - Soil-Transmitted Helminths - Product Description 66
Table 146: Technical University of Munich Pipeline Products & Ongoing Clinical Trials Overview 67
Table 147: Malaria Blood Test - Product Status 67
Table 148: Malaria Blood Test - Product Description 67
Table 149: University of Delhi Pipeline Products & Ongoing Clinical Trials Overview 68
Table 150: Rapid Diagnostic Kit - Trichomonas Vaginalis - Product Status 68
Table 151: Rapid Diagnostic Kit - Trichomonas Vaginalis - Product Description 68
Table 152: University of Nevada Reno Pipeline Products & Ongoing Clinical Trials Overview 69
Table 153: Diagnostic Assay - Aspergillosis - Product Status 69
Table 154: Diagnostic Assay - Aspergillosis - Product Description 69
Table 155: Diagnostic Assay - Fungal Disease - Product Status 70
Table 156: Diagnostic Assay - Fungal Disease - Product Description 70
Table 157: Diagnostic Assay - Tinea Capitis - Product Status 70
Table 158: Diagnostic Assay - Tinea Capitis - Product Description 71
Table 159: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 72
Table 160: Point-of-Care Biomarker Test - Malaria - Product Status 72
Table 161: Point-of-Care Biomarker Test - Malaria - Product Description 72
Table 162: Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview 73
Table 163: Rapid Diagnostic Test - Leishmaniasis - Product Status 73
Table 164: Rapid Diagnostic Test - Leishmaniasis - Product Description 73
Table 165: Glossary 89

1.2 List of Figures
Figure 1: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 10
Figure 2: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 11
Figure 3: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 12
Figure 4: Parasitology & Mycology Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 13

【掲載企業】

Abingdon Health Ltd
Access Bio Inc
AdvanDx Inc
Akers Biosciences Inc
Ampath Trust
Amplino B.V.
Antigen Discovery Inc
Atlas Genetics Ltd
Atomo Diagnostics Pty Limited
BBB Technologies Inc
Bruker Daltonik GmbH
Ceres Nanosciences Inc
Chembio Diagnostic Systems Inc
CrossLife Technologies Inc
DetectoGen Inc
DxDiscovery, Inc.
DxNA LLC
Eiken Chemical Co Ltd
Fast-track diagnostics S.a.r.l.
Foundation for Innovative New Diagnostics
genedrive plc
GenePOC Inc
GlucoSentient Inc
Group K Diagnostics
Innova Biotechnology Co Ltd
Institute for Development Research
Institute of Molecular Biology of Parana
Labsystems Diagnostics Oy
Makerere University
mBio Diagnostics Inc
Meridian Bioscience Inc
Meru University of Science & Technology
Micronics Inc
Molbio Diagnostics Pvt. Ltd.
MycoMed Technologies, LLC
NG Biotech
NOWDiagnostics
PATH medical GmbH
Protein Advances Inc
Singapore Immunology Network
Stanford University
Technical University of Munich
University of Delhi
University of Nevada Reno
Vanderbilt University
Whidiag SAS

★調査レポート[寄生虫・菌類迅速検査およびPOC:医療機器パイプライン分析2017] (コード:GDME0431EPD)販売に関する免責事項を必ずご確認ください。
★調査レポート[寄生虫・菌類迅速検査およびPOC:医療機器パイプライン分析2017]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆